AVA32-01

N/A

Report date: 2023/10/30 11:43:24

Base Information

Drug NameAVA32-01
Drug Alias NameAVA32-01AVA-32-01
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Programmed death-ligand 1Anti-IL15
TargetsProgrammed death-ligand 1Interleukin-15
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A